Resources
Clear, Evidence-Led Reading on Benign Conditions
Articles and videos to help patients and referrers understand the conditions Dr Shaffer treats, and where low-dose radiotherapy fits. Choose a condition to see its articles and video.
On-Treatment Serum Prostate-Specific Antigen and Overall Survival in Prostate Cancer (STAMPEDE Platform Protocol): A Post-Hoc Analysis of Data From Five Phase 3 Trials
Co-authored by Dr Richard Shaffer.
Read paperAbiraterone Acetate Plus Prednisolone With or Without Enzalutamide for Patients With Metastatic Prostate Cancer Starting Androgen Deprivation Therapy: Final Results From Two Randomised Phase 3 Trials of the STAMPEDE Platform Protocol
Co-authored by Dr Richard Shaffer.
Read paperTreatment of Dupuytren's Disease With Post-Interventional Radiotherapy
Co-authored by Dr Richard Shaffer.
Read paperA High-Throughput in Vitro Radiobiology Platform for Megavoltage Photon Linear Accelerator Studies
Co-authored by Dr Richard Shaffer.
Read paperAbiraterone Acetate and Prednisolone With or Without Enzalutamide for High-Risk Non-Metastatic Prostate Cancer: A Meta-Analysis of Primary Results From Two Randomised Controlled Phase 3 Trials of the STAMPEDE Platform Protocol
Co-authored by Dr Richard Shaffer.
Read paperFolate Depletion as a Radiosensitizing Strategy for Solid Tumors
Co-authored by Dr Richard Shaffer.
Read paperIn Vitro Evaluation of Notch Inhibition to Enhance Efficacy of Radiation Therapy in Melanoma
Co-authored by Dr Richard Shaffer.
Read paperOC-0449: Pre-Clinical Evaluation of Combining Radiation With Notch Signalling Inhibition in Melanoma
Co-authored by Dr Richard Shaffer.
Read paperHydroxychloroquine and Short-Course Radiotherapy in Elderly Patients With Newly Diagnosed High-Grade Glioma: A Randomized Phase II Trial
Co-authored by Dr Richard Shaffer.
Read paperA Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-Grade Glioma
Co-authored by Dr Richard Shaffer.
Read paperEP-1673 Implementation of a Collaborative Fast Access Radiotherapy Program for Benign Disease
Co-authored by Dr Richard Shaffer.
Read paperA PHASE I EXPANSION STUDY of PEGARGIMINASE, CISPLATIN and PEMETREXED in ARGININOSUCCINATE SYNTHETASE 1-NEGATIVE RECURRENT HIGH GRADE GLIOMAS (HGGS)
Co-authored by Dr Richard Shaffer.
Read paperP01.072 Hydroxychloroquine and Short Course Radiotherapy for Elderly Patients With Glioma: A Randomised Study
Co-authored by Dr Richard Shaffer.
Read paperA Phase I Expansion Study of Pegargiminase, Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-negative Recurrent High Grade Gliomas (HGGs).
Co-authored by Dr Richard Shaffer.
Read paperEP-2312: Biological Validation of a High-Throughput In-Vitro Radiobiology Platform
Co-authored by Dr Richard Shaffer.
Read paperEP-2311: Biological Effects of Radiation Dose-Rate and Intra-Fraction Breaks in Stereotactic Radiotherapy
Co-authored by Dr Richard Shaffer.
Read paperAdding Abiraterone or Docetaxel to Long-Term Hormone Therapy for Prostate Cancer: Directly Randomised Data From the STAMPEDE Multi-Arm, Multi-Stage Platform Protocol
Co-authored by Dr Richard Shaffer.
Read paperPO-0990: Combining Radiotherapy and Notch Inhibition in Melanoma
Co-authored by Dr Richard Shaffer.
Read paperImproving Clinical Oncology Trainees' Radiotherapy Induction
Co-authored by Dr Richard Shaffer.
Read paperThe Role of Oncologists in Management Decisions for Non-Metastatic Muscle Invasive Bladder Cancer (MIBC)
Co-authored by Dr Richard Shaffer.
Read paperEP-1706: Evaluation of Different Radiosurgical Planning Techniques Using IPlan®
Co-authored by Dr Richard Shaffer.
Read paperRadiotherapy for Benign Disease; Assessing the Risk of Radiation-Induced Cancer Following Exposure to Intermediate Dose Radiation
Co-authored by Dr Richard Shaffer.
Read paperRadiotherapy for Benign Disease: Current Evidence, Benefits and Risks
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy for Intraprostatic Maximal Simultaneous Boost (IMAX): Dosimetric Analyses, Safety and Early Clinical Outcomes
Co-authored by Dr Richard Shaffer.
Read paperNon-Melanoma Skin Cancer
Co-authored by Dr Richard Shaffer.
Read paperDeriving Prostate Alpha-Beta Ratio Using Carefully Matched Groups, Long Follow-Up and the Phoenix Definition of Biochemical Failure
Co-authored by Dr Richard Shaffer.
Read paperA Radiotherapy Planning Study of RapidArc, Intensity Modulated Radiotherapy, Three-Dimensional Conformal Radiotherapy, and Parallel Opposed Beams in the Treatment of Pediatric Retroperitoneal Tumors
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy (VMAT) and Conventional IMRT for Simultaneous Maximal Intra-Prostatic Boost
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes
Co-authored by Dr Richard Shaffer.
Read paper173 11C-METHIONINE POSITRON EMISSION TOMOGRAPHY to ASSESS TREATMENT RESPONSE of ACOUSTIC NEUROMAS to STEREOTACTIC IRRADIATION
Co-authored by Dr Richard Shaffer.
Read paper194 FUNCTIONAL MAGNETIC RESONANCE IMAGING of ACOUSTIC NEUROMAS AFTER STEREOTACTIC IRRADIATION
Co-authored by Dr Richard Shaffer.
Read paperHeroin-Induced Leucoencephalopathy Misdiagnosed as Psychiatric Illness
Co-authored by Dr Richard Shaffer.
Read paperA Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas
Co-authored by Dr Richard Shaffer.
Read paperIn Response to Dr Belkacemi Et Al
Co-authored by Dr Richard Shaffer.
Read paperQuadrant Dosimetry as a Predictor of Biochemical Relapse in I-125 Prostate Brachytherapy
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Simultaneous Maximal Intraprostatic Boost: A Planning Comparison Study
Co-authored by Dr Richard Shaffer.
Read paperAcute Cardiotoxicity With Concurrent Trastuzumab and Radiotherapy Including Internal Mammary Chain Nodes: A Retrospective Single-Institution Study
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy (VMAT) for Delivery of Prostate Radiotherapy: Reduction in Treatment Time and Monitor Unit Requirements Compared to Intensity Modulated Radiotherapy
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Arc Therapy (VMAT) Reduces Treatment Time Compared to Conventional IMRT (CIMRT) While Maintaining Similar Plan Quality in Whole Pelvic Gynecologic Radiotherapy
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy (VMAT) Reduces Treatment Time and Improves Dosimetry Compared to Conventional Intensity Modulated Radiotherapy (IMRT) for Frontal and Temporal High-Grade Gliomas (HGG)
Co-authored by Dr Richard Shaffer.
Read paperVolumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
Co-authored by Dr Richard Shaffer.
Read paperPrevalence and Associations of Vitamin D Deficiency in Foreign-Born Persons With Tuberculosis in London
Co-authored by Dr Richard Shaffer.
Read paper